Yesbolat Sakko

Mr. Yesbolat Sakko

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
AGArnur Gusmanov
Arnur Gusmanov
GZGulnur Zhakhina
Gulnur Zhakhina
SYSauran Yerdessov
Sauran Yerdessov
YSYesbolat Sakko
Yesbolat Sakko
KMKamilla Mussina
Kamilla Mussina
AGAbduzhappar Gaipov
Abduzhappar Gaipov

17 April 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
AMAnna Midlenko
Anna Midlenko
KMKamilla Mussina
Kamilla Mussina
GZGulnur Zhakhina
Gulnur Zhakhina
YSYesbolat Sakko
Yesbolat Sakko
GRGyunel Rashidova
Gyunel Rashidova
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Background: Although there are numerous sources of epidemiologic information on breast cancer in Kazakhstan, none of them have specifically examined the burden of this disease. Therefore, this article aims to provide an overview of the breast cancer prevalence, incidence, mortality, and distribution and changes over time in Kazakhstan based on nationwide large-scale healthcare data from the National Registry in order to encourage more research on the impact of various diseases at the regional and national levels.Methods: The study cohort included all adult women older than 25 years who were diagnosed with breast cancer in any clinical setting of the Republic of Kazakhstan during the period of 2014–2019. The data were extracted from the Unified Nationwide Electronic Health System (UNEHS) to get an overview of descriptive statistics, incidence, prevalence, and mortality rate calculations and the Cox proportional hazards regression model. All survival functions and factors associated with mortality were tested for significance.Results: The cohort population (n = 55,465) comprised subjects with the age at the diagnosis of breast cancer from 25 to 97 years, with a mean of 55.7 ± 12.0 years. The majority of the study population belonged to the age group 45–59 years, which is 44.8% of the cohort. The all-cause mortality rate of the cohort is 16%. The prevalence rate increased from 30.4 per 10,000 population in 2014 to 50.6 in 2019. The incidence rate varied from 4.5 per 10,000 population in 2015 to 7.3 in 2016. Mortality rates were stable and high in the senile age patients (75–89 years old). Breast cancer mortality was positively associated with women who had been diagnosed with diabetes, HR 1.2 (95% CI, 1.1–2.3), whereas it was negatively associated with arterial hypertension, HR 0.4 (95% CI, 0.4–0.5).Conclusion: Overall, Kazakhstan is experiencing an increase in the incidence of breast cancer cases, but the mortality rate has started to decline. The switch to population mammography screening could reduce the breast cancer mortality rate. These findings should be utilized to help Kazakhstan determine what cancer control priorities should be utilized, including the need to implement efficient and affordable screening and prevention programs.

11 November 2022 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
DGDinara Galiyeva
Dinara Galiyeva
AGArnur Gusmanov
Arnur Gusmanov
YSYesbolat Sakko
Yesbolat Sakko
AIAlpamys Issanov
Alpamys Issanov
KAKuralay Atageldiyeva
Kuralay Atageldiyeva
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Background: We aimed to explore descriptive epidemiology of T1 and T2 Diabetes Mellitus (DM) and to investigate demographic factors and comorbidities associated with all-cause mortality by aggregating and utilizing large-scale administrative healthcare data from the Unified National Electronic Health System (UNEHS) of Kazakhstan for 2014–2019 years period. Methods: A total of 475,539 individuals were included in the analyses. The median years of follow-up for Type 1 DM patients accounted for 4.7 years and 4.5 years in Type 2 DM patients. We used Kaplan-Meier and log-rank test to calculate failure function and differences in survival by age, sex, ethnicity, and comorbidities with all-cause mortality for Type 1 and Type 2 DM. Cox proportional hazards regression analysis was used to obtain crude and adjusted hazard ratios. Results: Prevalence of Type 1 and Type 2 DM increased 1.7 times from 2014 to 2019. Mortality of Type 1 and Type 2 DM also increased 4 times and 6 times from 2014 to 2019, respectively. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh in patients with Type 1 and Type 2 DM. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death. Conclusion: The prevalence and mortality rate of Type 1 and Type 2 DM increased during the years 2014–2019 in Kazakhstan. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death.

11 October 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
YSYesbolat Sakko
Yesbolat Sakko
MMMeruyert Madikenova
Meruyert Madikenova
AKAlexey Kim
Alexey Kim
DSDmitriy Syssoyev
Dmitriy Syssoyev
KMKamilla Mussina
Kamilla Mussina
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Objectives This study aims to estimate tuberculosis (TB) incidence, mortality rates and survival HRs in Kazakhstan, using large-scale administrative health data records during 2014–2019. Design A retrospective cohort study. Settings Data for patients with TB in Kazakhstan during 2014–2019, reported in the Unified National Electronic Healthcare System. Participants Patients with TB in Kazakhstan (ICD-10 (The International Classification of Diseases, 10th revision) codes: A15–A19). Outcome measures Demographic factors, diagnoses and comorbidities were analysed using descriptive, bivariate and multivariable statistical analyses. TB incidence and mortality rates were calculated, and Cox regression and Kaplan-Meier survival analysis were performed to assess risk factors for survival rates. Results Of the 149 122 patients with TB, 91 437 (61%) were males, and 139 931 (94%) had respiratory TB. From 2014 to 2019, TB incidence declined from 227 to 15.2 per 100 000 individuals, while all-cause mortality increased from 8.4 to 15.2 per 100 000. Age-specific TB incidence was lowest for 0–10 years of age and highest for 20 years of age. Being older, man, urban residence versus rural, retired versus employed, having HIV and having diabetes versus no comorbidities were associated with lower survival rates. Conclusion To date, this is the largest TB published study for Kazakhstan, characterising TB incidence and mortality trends by demographic factors, and risk factors for survival rates. The findings highlight the need for targeted interventions to address the growing burden of TB, particularly among older adults, men, urban residents and those with HIV and diabetes. The study underscores the importance of using administrative health data to inform policy and health system responses to TB in Kazakhstan.

2 August 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
GZGulnur Zhakhina
Gulnur Zhakhina
AGAbduzhappar Gaipov
Abduzhappar Gaipov
ASAlessandro Salustri
Alessandro Salustri
AGArnur Gusmanov
Arnur Gusmanov
YSYesbolat Sakko
Yesbolat Sakko
OAOguz Akbilgic
Oguz Akbilgic
Background: Cardiovascular diseases contribute to premature mortality globally, resulting in substantial social and economic burdens. The Global Burden of Disease (GBD) Study reported that in 2019 alone, heart attack and strokes accounted for the deaths of 18.6 million individuals. Ischemic heart diseases, including acute myocardial infarction (AMI), accounted for 182 million disability-adjusted life years (DALYs) and it is leading cause of death worldwide.Aim: The aim of this study is to present the burden of AMI in Kazakhstan and describe the outcome of hospitalized patients.Methods: The data of 79,172 people admitted to hospital with ICD-10 diagnosis I21 between 2014 and 2019 was derived from the Unified National Electronic Health System and retrospectively analyzed.Results: The majority of the cohort (53,285, 67%) were men, with an average age of 63 (±12) years, predominantly of Kazakh (38,057, 48%) and Russian (24,583, 31%) ethnicities. Hypertension was the most common comorbidity (61,972, 78%). In males, a sharp increase in incidence is present after 40 years, while for females, the morbidity increases gradually after 55. Throughout the observation period, all-cause mortality rose from 101 to 210 people per million population (PMP). In 2019, AMI account for 169,862 DALYs in Kazakhstan, with a significant proportion (79%) attributed to years of life lost due to premature death (YLDs). Approximately half of disease burden due to AMI (80,794 DALYs) was in age group 55–69 years. Although incidence is higher for men, they have better survival rates than women. In terms of revascularization procedures, coronary artery bypass grafting yielded higher survival rates compared to percutaneous coronary intervention (86.3% and 80.9% respectively) during the 5-year follow-up.Conclusion: This research evaluated the burden and disability-adjusted life years of AMI in Kazakhstan, the largest Central Asian country. The results show that more effective disease management systems and preventive measures at earlier ages are needed.

4 September 2023 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
YSYesbolat Sakko
Yesbolat Sakko
ATAkbayan Turesheva
Akbayan Turesheva
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Gulzhanat AimagambetovaGulzhanat Aimagambetova
Gulzhanat Aimagambetova
TUTalshyn Ukybassova
Talshyn Ukybassova
KAKuralay Atageldiyeva
Kuralay Atageldiyeva
Introduction: Spontaneous pregnancy loss (SPL) is a common health problem that affects 1:10 of childbearing women, and is linked with physical and psychological complications. As the number of nationwide studies on the incidence of SPL is few, especially from middle‐income countries, in this study we investigated the epidemiology, complications and outcomes of SPL before 22 weeks of gestation by analyzing large‐scale healthcare data from the Unified Nationwide Electronic Healthcare System (UNEHS) in Kazakhstan.Material and methods: A population‐based study among women who experienced SPL in any healthcare setting of the Republic of Kazakhstan during the period of 2014–2019. The International Classification of Diseases (ICD) 10th edition and ICD 9th edition's procedural codes were utilized to retrieve data using relevant diagnostic and procedural codes.Results: In total, 207 317 records of women who have experienced an SPL before 22 weeks of gestation were analyzed from all Kazakhstani regions. The estimated prevalence of SPL was 8.7%, with a 20% decline over a 6‐year period. The SPL cases ratio comprises on average 6.2 per 1000 reproductive‐age women. Incomplete miscarriage (ICD‐10 code “O03.4”) was the most common type (37.8%), followed by blighted ovum (ICD‐10 code “O02.0”; 34.1%) and missed abortion (ICD‐10 code “O02.1”; 13.5%). The most common management methods were dilation and curettage of the uterus (ICD‐9 code “69.0”; 84.7%) and aspiration curettage of the uterus (ICD‐9 code “65.0”; 15%), whereas medical management was rarely performed (2.6%).Conclusion: The information available in UNEHS adequately identifies types of miscarriages and treatment methods. Although the prevalence of SPL before 22 weeks of gestation is decreasing, management of miscarriages requires closer attention.